UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

Prevalence and Risk Factors for Pulmonary Arterial Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization: A Webthal Study

Circulation (New York, N.Y.), 2014-01, Vol.129 (3), p.338-345

2014

Volltextzugriff (PDF)

Anemia in β-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression

Haematologica (Roma), 2008-01, Vol.93 (1), p.111-115

2008

Volltextzugriff (PDF)

A genetic score for the prediction of beta-thalassemia severity

Haematologica (Roma), 2015-04, Vol.100 (4), p.452

2015

Volltextzugriff (PDF)

Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion

Haematologica (Roma), 2012-07, Vol.97 (7), p.989-993

2012

Volltextzugriff (PDF)

Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis

Proceedings of the National Academy of Sciences - PNAS, 2012-09, Vol.109 (36), p.14562-14567

2012

Volltextzugriff (PDF)

Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?

Digestive and liver disease, 2016-06, Vol.48 (6), p.650-655

2016

Volltextzugriff (PDF)

IFNL3 polymorphisms and HCV infection in patients with beta thalassemia

Annals of hepatology, 2015-05, Vol.14 (3), p.389-395

2015

Volltextzugriff (PDF)

Amelioration of Sardinian β0 thalassemia by genetic modifiers

Blood, 2009-10, Vol.114 (18), p.3935-3937

2009

Volltextzugriff (PDF)

Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry

British journal of haematology, 2014-10, Vol.167 (1), p.121-126

2014

Volltextzugriff (PDF)

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B

Gut, 2013-02, Vol.62 (2), p.290-298

2013

Volltextzugriff (PDF)

Feasibility, reproducibility, and reliability for the T2 iron evaluation at 3 T in comparison with 1.5 T

Magnetic resonance in medicine, 2012-08, Vol.68 (2), p.543-551

2012

Volltextzugriff (PDF)

Association of chronic hepatitis C with recurrent brief depression

Journal of affective disorders, 2012-12, Vol.141 (2), p.361-366

2012

Volltextzugriff (PDF)

Standardized T 2 map of normal human heart in vivo to correct T 2 segmental artefacts

NMR in biomedicine, 2007-10, Vol.20 (6), p.578-590

2007

Volltextzugriff (PDF)

Standardized T2 map of normal human heart in vivo to correct T2 segmental artefacts

NMR in biomedicine, 2007-10, Vol.20 (6), p.578-590

2007

Volltextzugriff (PDF)

Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone

Blood cells, molecules, & diseases, 2010-08, Vol.45 (2), p.136-139

2010

Volltextzugriff (PDF)

Hepatocellular carcinoma in the thalassaemia syndromes

British journal of haematology, 2004-01, Vol.124 (1), p.114-117

2004

Volltextzugriff (PDF)

Hépatite B

2021

Volltextzugriff (PDF)

Two-Year Renal Hemodynamic Effects of Deferasirox in Patients with Transfusion-Dependent β-Thalassemia

Blood, 2012-11, Vol.120 (21), p.3257-3257

2012

Volltextzugriff (PDF)

CMR Survey In a Large Cohort Of TI Patients

Blood, 2013-11, Vol.122 (21), p.1015-1015

2013

Volltextzugriff (PDF)

Estimation of the Prevalence of Pulmonary Artery Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization

Blood, 2012-11, Vol.120 (21), p.3262-3262

2012

Volltextzugriff (PDF)

CMR survey in Thalassemia Intermedia patients

Journal of cardiovascular magnetic resonance, 2014-01, Vol.16 (Suppl 1), p.P267-P267, Article P267

2014

Volltextzugriff (PDF)

Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy

Clinical practice and epidemiology in mental health, 2007-10, Vol.3 (22), p.22-22

2007

Volltextzugriff (PDF)

Thalassemia intermedia is associated with a proatherogenic biochemical phenotype

Blood cells, molecules, & diseases, 2011-04, Vol.46 (4), p.294-299

2011

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Aktive Filter

ThemaFollow-Up Studies

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(33)
Science & Technology
(32)
Life Sciences & Biomedicine
(30)
Male
(24)
Female
(23)
Adult
(19)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Middle Aged
(15)
Hematology
(9)
Endocrinology & Metabolism
(7)
Anemias. Hemoglobinopathies
(6)
Beta-Thalassemia - Complications
(6)
Diseases Of Red Blood Cells
(6)
Hematologic And Hematopoietic Diseases
(6)
Hepatitis C
(6)
Hepatitis C Virus
(6)
Iron Overload
(6)
Treatment Outcome
(6)
Adolescent
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence and Risk Factors for Pulmonary Arterial Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization: A Webthal Study

Anemia in β-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression

A genetic score for the prediction of beta-thalassemia severity

Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion

Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis

Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?

Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with β-thalassemia

IFNL3 polymorphisms and HCV infection in patients with beta thalassemia

Amelioration of Sardinian β0 thalassemia by genetic modifiers

Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry

Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B

Feasibility, reproducibility, and reliability for the T2 iron evaluation at 3 T in comparison with 1.5 T

Association of chronic hepatitis C with recurrent brief depression

Standardized T 2 map of normal human heart in vivo to correct T 2 segmental artefacts

Standardized T2 map of normal human heart in vivo to correct T2 segmental artefacts

Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone

Hepatocellular carcinoma in the thalassaemia syndromes

Hépatite B

Two-Year Renal Hemodynamic Effects of Deferasirox in Patients with Transfusion-Dependent β-Thalassemia

CMR Survey In a Large Cohort Of TI Patients

Estimation of the Prevalence of Pulmonary Artery Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial

CMR survey in Thalassemia Intermedia patients

Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy

Thalassemia intermedia is associated with a proatherogenic biochemical phenotype

Aktive Filter

Suchergebnisse filtern